The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: UK vaccine record, Turkish lira, Strict restrictions

Sun, 21st Mar 2021 12:55

(Sharecast News) - The UK's vaccine record was once again broken yesterday, the Department for Health has confirmed, with 873,784 vaccinations registered. This breaks down into 686,424 first doses and 70,449 second doses in England; 59,415 first doses and 13,160 second doses in Scotland; 26,939 first doses and 9,429 second doses in Wales; and 4,785 first doses and 3,183 second doses in Northern Ireland. Yesterday's figures also represent a record amount of first doses in the UK, as well as a record number of doses overall. - Sunday Telegraph

The Turkish lira could plunge up to 15% in an "ugly reaction" when financial markets reopen on Monday, analysts have warned, after president Recep Tayyip Erdogan sacked the country's central bank chief days after a sharp rise in interest rates. - Guardian

The defence secretary, Ben Wallace, has said the government will protect the success of its vaccination programme at all costs, as speculation grows that strict restrictions on foreign travel could continue into the summer. With cases rising in several EU countries and the South African variant becoming more prevalent in France, some experts have cautioned against lifting the holiday ban. - Guardian

Hargreaves Lansdown, one of the UK's top 100 stock market-listed firms, faces being dragged through court as a result of its aggressive promotion of Woodford Equity Income right up until the shockingly mismanaged investment fund closed. Today, The Mail on Sunday can exclusively reveal that litigation specialist RGL Management has formally launched a legal action against the wealth manager to recover the losses that investors incurred in the wake of the £3.8billion fund being shut in June 2019 - and then broken up. - Financial Mail on Sunday

Deliveroo's blockbuster share offering faces a rough ride after institutional investors baulked at the firm's £7.5billion valuation. Two fund managers who run multi-billion pound portfolios told The Mail on Sunday they wouldn't buy any shares at the price offered by the company's brokers. One said the float was 'ludicrously priced'. Another big investor said: 'They want a high price but the firm didn't make any money last year.' - Financial Mail on Sunday

The co-working giant behind the Regus and Spaces brands is trying to strong-arm London landlords into offering more favourable terms as the company suffers from the trend towards home working. IWG, led by Mark Dixon, has filed notice of its intention to appoint administrators to subsidiaries holding the leases to its offices in Broadgate Tower in the City, Covent Garden, Pall Mall, Chiswick and St Mary Axe. The move could be intended to pressure landlords into swallowing inferior terms. - Sunday Times

An 82-year-old grandmother, a vicar in Devon and a former BP worker are among the shareholders applying pressure on Barclays after the bank was identified as Europe's largest backer of fossil fuels. The Rev Canon Dr John Hall is among more than 100 investors to back a resolution demanding that Barclays phase out its financing for coal, oil and gas companies. The 71-year-old from Devon said action from major companies was needed to fight climate change. - Sunday Telegraph

Consumers are facing price rises and shortages of products from TVs and mobile phones to cars and games consoles as a global shortage in semiconductors grows. The shortage in chips, the "brain" within every electronic device in the world, has been steadily worsening since last year. Initially the problem was only a temporary delay in supplies as factories shut down when the coronavirus pandemic first hit. However, although production is back to normal a new surge in demand driven by changing habits fuelled by the pandemic means that it is now reaching crisis point. - Guardian

Bike retailers and manufacturers are struggling to keep up with demand as the cycling boom kicked off by the pandemic rolls into 2021, with customers falling on available stock "like pirahanas", according to one big retailer. UK bicycle sellers said stock was being snapped up within days of arriving at ports even before the market hits its peak selling season, which usually begins at Easter. - Guardian

Investment trusts have loaded up on debt to supercharge returns amid expectations of a British stock ­market revival. Listed funds can borrow money to increase how much they invest in stocks. The process - known as gearing - can boost returns when share prices rise but can also lead to larger losses if stock picks turn sour. The ability to borrow sets trusts apart from ordinary funds, which can invest only the money entrusted to them by savers. - Sunday Telegraph

A new ratings system for large electrical goods is being introduced this month in a move that could result in household bills being cut by as much as £100 a year. It is part of a shake-up of the efficiency grading system by the Government for new products such as fridges, washing machines and TVs. It involves new energy labels stuck on the side of 'white goods' that must adhere to tougher energy efficiency standards than were previously demanded. - Financial Mail on Sunday

The EU today doubled down on its threat to block Covid vaccine exports to the UK as the British Government warned Brussels that 'the world is watching'. European Commissioner for financial services Mairead McGuinness said 'everything is on the table' and the EU's focus is on 'protecting our citizens'. She also said there is a need for both sides to 'calm down' amid the escalating war of words over vaccine supply but her decision to repeat Ursula von der Leyen's threat is unlikely to dampen tensions. - Financial Mail on Sunday

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.